Immediate Pause in the Administration of the Johnson and Johnson COVID-19 vaccine


The FDA is recommending an immediate pause in the administration of the Johnson and Johnson (Janssen) COVID-19 vaccine due reports of six cases of a rare and serious clot (cerebral venous sinus thrombosis)…there has been one associated death…for context, 6.8 million doses of the Johnson and Johnson COVID-19 vaccine have been administered…a link to the FDA statement is below.

Consequently, all CommonSpirit Health facilities should immediately halt administration of the Johnson and Johnson COVID-19 vaccine…there will be an emergency session of the Advisory Committee on Immunization Practices (ACIP) tomorrow (Wednesday, April 14) to review the data…additional guidance might be forthcoming after ACIP meets.

Please be sure all of your sites are aware of this development…our pharmacy and patient safety teams are working to provide additional information today.

Read the full story at the FDA Website.

Publish Date: 

Wednesday, April 14, 2021

News

CommonSpirit Health Announces FY2022 Q1 Results

NOV 16, 2021

CHICAGO – Nov. 16, 2021 -- CommonSpirit Health released financial results today for its fiscal year 2022 first quarter.

Read More Additional information about CommonSpirit Health Announces FY2022 Q1 Results

Lloyd Dean: The stakes for health system CEOs are higher

NOV 04, 2021

In this interview with Becker's, CEO Lloyd Dean reflects on how his leadership style has evolved, how health care is changing, and his upcoming retirement.

Read More Additional information about Lloyd Dean: The stakes for health system CEOs are higher

CommonSpirit implements vaccine requirement with 97% compliance rate

NOV 04, 2021

Nearly 97% of our employees are now vaccinated or have received an approved medical or religious exemption. We are deeply grateful to all of our employees who have chosen to get vaccinated.

Read More Additional information about CommonSpirit implements vaccine requirement with 97% compliance rate